返回
Ascentage Pharma Group International (ASPHF) 财务
ASPHF 股价走势图
ASPHF 财务
Ascentage Pharma Group International
$8.48
0%
$0
收盘价：Mar 24, 16:00:00 GMT-4
$8.48
0%
$0
盘后：Mar 24, 20:00:00 GMT-4
关键数据
前收盘价
$8.48
开盘价
$8.48
当日区间
$8.48 - $8.48
52周范围
$5.82 - $10.65
交易量
100
平均成交量
59
股息收益率
--
每股收益（TTM）
-0.52
市值
$788.3M
什么是 ASCENTAGE PHARMA GROUP INTL？
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.